{"id":15087,"date":"2019-11-06T11:39:14","date_gmt":"2019-11-06T10:39:14","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=15087"},"modified":"2023-03-01T13:48:45","modified_gmt":"2023-03-01T12:48:45","slug":"presa-m-soria-a-oyaguez-i-espinosa-e-echave-m-berrocal-a-manzano-jl-suarez-j-polanco-c","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/presa-m-soria-a-oyaguez-i-espinosa-e-echave-m-berrocal-a-manzano-jl-suarez-j-polanco-c\/","title":{"rendered":"Presa M, Soria A, Oyag\u00fcez I, Espinosa E, Echave M, Berrocal A, Manzano JL, Suarez J, Polanco C"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong style=\"text-align: justify;\">Presa M, Soria A, Oyag\u00fcez I, Espinosa E, Echave M, Berrocal A, Manzano JL, Suarez J, Polanco C<\/strong><\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<div class=\"col80\">\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6 style=\"text-align: justify;\">Nivolumab-adjuvant therapy for resected stage III-IV melanoma: a cost-effectiveness analysis for Spain<\/h6>\n<h6 style=\"text-align: justify;\"><strong>22nd<\/strong><strong> Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2022\/03\/258.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Presa M, Soria A, Oyag\u00fcez I, Espinosa E, Echave M, Berrocal A, Manzano JL, Suarez J, Polanco C &nbsp; &nbsp; Nivolumab-adjuvant therapy for resected stage III-IV melanoma: a cost-effectiveness analysis for Spain 22nd Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,928,246],"tags":[],"class_list":["post-15087","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-oncologia","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15087"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=15087"}],"version-history":[{"count":2,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15087\/revisions"}],"predecessor-version":[{"id":23176,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15087\/revisions\/23176"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=15087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=15087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=15087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}